years, we’re not particularly surprised to see Mylan make a bid for Perrigo. After Pfizer’s recent acquisition of Hospira , Perrigo remains among the few last sizable generic firms with unique niche attributes (compared with smaller firms like
April 7 (Reuters) - Hospira Inc , which agreed in February to be bought by Pfizer Inc, said the U.S. Food and Drug Administration had sent it another warning letter detailing violations in standard drug manufacturing practices at one of its facilities.
April 7 (Reuters) - Hospira Inc , which agreed in February to be acquired by Pfizer Inc, said it received a warning letter from the U.S. Food and Drug Administration related to its manufacturing...
Catalent Pharma Solutions DeRoyal Industries Eastman Chemical Gerresheimer Group Heritage Pioneer Corporate Group Honeywell Hospira Janco Kimberly-Clark MeadWestvaco Medline Industries Oliver Products Company Owens-Illinois Pharma Packaging Solutions
with 3G Capital and Heinz, backed by Berkshire Hathaway BRK.A BRK.B. Other deals included Pfizer's PFE purchase of Hospira HSP and UnitedHealth UNH buying pharmacy benefits manager Catamaran CTRX. There were also numerous other bolt-on acquisitions
Pfizer ( PFE ) announced the acquisition of Hospira ( HSP ) for $90 per share or $17 billion ..... premium on top of a large run-up for Hospira , the biggest provider of injectable drugs ..... the market has significantly undervalued Hospira . After a long hiatus, M&A bounced
We think Hospira posted a decent fourth quarter, considering ..... purchase the company. We continue to believe Hospira 's biosimilars pipeline, the recent ..... overcome the recent patent loss on Precedex. Hospira 's narrow economic moat remains intact
stock news, [TICKER:PFE] Pfizer (PFE) announced that it's paying a pretty decent premium to acquire [TICKER:HSP] Hospira (HSP). What's our take on that deal? Glaser: Damien Conover, our Pfizer analyst, thinks that it's going to be a
Feb 5 (Reuters) - Pfizer Inc said it would buy Hospira Inc for about $15 billion to boost its portfolio of generic injectable drugs and copies of biotech medicines.
Pfizer's PFE announced acquisition of Hospira HSP doesn't materially change our fair ..... price. However, we plan to raise our Hospira fair value estimate to the acquisition ..... specialty injectable pharmaceuticals (68% of Hospira sales), which should strengthen the